Advancing Claude in healthcare and the life sciences
read at source ↗ www.anthropic.com
Advancing Claude in healthcare and the life sciences
Source: Anthropic Date: 2026-01-11 URL: https://www.anthropic.com/news/healthcare-life-sciences
Summary
Anthropic announced HIPAA-ready Claude for Healthcare (providers, payers, health tech) and expanded Claude for Life Sciences (clinical trials, regulatory submissions). New connectors: healthcare (CMS Coverage Database, ICD-10, NPI Registry, PubMed 35M+ articles); life sciences (Medidata, ClinicalTrials.gov, bioRxiv/medRxiv, ChEMBL, Open Targets). Agent Skills: FHIR development, prior authorization review, clinical trial protocol drafting, regulatory submission support. Claude Opus 4.5 showing major advances on MedCalc, MedAgentBench, SpatialBench. Partners: Banner Health, Novo Nordisk, Sanofi, Genmab, Flatiron Health (16+ total).
Implications
- Enterprise / healthcare vertical full stack. HIPAA-ready infrastructure + domain-specific connectors + agent skills = complete healthcare AI platform, not just a model API. The PubMed (35M articles) + clinical trial databases + medical coding databases combination addresses the full clinical workflow.
- Prior authorization as the wedge. Prior authorization review (insurance authorization for medical procedures) is the single most time-consuming administrative burden in US healthcare — it costs ~$35B annually in administrative time. Claude’s prior authorization review agent directly attacks the highest-value administrative pain point.
- FHIR development as developer capability. FHIR (Fast Healthcare Interoperability Resources) is the standard for healthcare data exchange. A Claude agent skill for FHIR development means Anthropic is helping health IT teams build compliant interoperability infrastructure — a B2B developer tool, not just a clinical tool.
- Claude Opus 4.5 on medical benchmarks. Publishing benchmark improvements specifically for medical reasoning (MedCalc, MedAgentBench) is the clinical credibility move — these are the benchmarks that healthcare enterprise buyers use to evaluate models for clinical decision support.
- Watch: whether HIPAA compliance was independently audited; how prior authorization review performance tracked against human reviewers; which of the 16+ launch partners became public reference cases.